PwC’s Global Health Industries network is pleased to present you with its 11th issue of the Asia-Pacific Health Industries Newsletter.
In this edition we highlight a number of recent developments that are of direct interest to Pharmaceutical & Life Sciences companies and healthcare organisations including:
- Changes in China’s compliance environment regarding disclosure regime with respect to the ethical obligations of health care professionals and institutions.
- Developments in pricing in China.
- Deals in Korea and India’s pharmaceutical industries.
- Digital Health and Big Data.
- Tax developments and changes across different areas: company tax rate and R&D tax offsets in Australia; new ordinance for Hong Kong corporate amalgamations; tax on M&A activities and restructuring strategies in China; update on wholly foreign invested medical institutions in China; and 2014 Budget changes in Singapore.